224 related articles for article (PubMed ID: 11391621)
1. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A
Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270
[TBL] [Abstract][Full Text] [Related]
3. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.
Wick W; Platten M; Weller M
J Neurooncol; 2001 Jun; 53(2):177-85. PubMed ID: 11716069
[TBL] [Abstract][Full Text] [Related]
4. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer.
Subramaniam V; Chakrabarti R; Prud'homme GJ; Jothy S
Anticancer Drugs; 2010 Apr; 21(4):351-61. PubMed ID: 20145538
[TBL] [Abstract][Full Text] [Related]
5. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
[TBL] [Abstract][Full Text] [Related]
6. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
7. Anti-platelet action of an anti-allergic agent, N-(3',4'-dimethoxycinnamoyl)anthranilic acid (tranilast).
Iwasa Y; Iwasa T; Matsui K; Yoshimura T; Tanaka N; Miyazaki K
Eur J Pharmacol; 1986 Jan; 120(2):231-4. PubMed ID: 2419148
[TBL] [Abstract][Full Text] [Related]
8. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts.
Yamada H; Tajima S; Nishikawa T; Murad S; Pinnell SR
J Biochem; 1994 Oct; 116(4):892-7. PubMed ID: 7533764
[TBL] [Abstract][Full Text] [Related]
9. Tranilast, an anti-allergic drug, down-regulates the growth of cultured neurofibroma cells derived from neurofibromatosis type 1.
Yamamoto M; Yamauchi T; Okano K; Takahashi M; Watabe S; Yamamoto Y
Tohoku J Exp Med; 2009 Mar; 217(3):193-201. PubMed ID: 19282654
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages.
Suzawa H; Kikuchi S; Ichikawa K; Koda A
Jpn J Pharmacol; 1992 Oct; 60(2):85-90. PubMed ID: 1282575
[TBL] [Abstract][Full Text] [Related]
11. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts.
Suzawa H; Kikuchi S; Arai N; Koda A
Jpn J Pharmacol; 1992 Oct; 60(2):91-6. PubMed ID: 1282576
[TBL] [Abstract][Full Text] [Related]
12. Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting.
Ward MR; Agrotis A; Kanellakis P; Hall J; Jennings G; Bobik A
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):940-8. PubMed ID: 12067902
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats.
Miyazawa K; Kikuchi S; Fukuyama J; Hamano S; Ujiie A
Atherosclerosis; 1995 Dec; 118(2):213-21. PubMed ID: 8770315
[TBL] [Abstract][Full Text] [Related]
14. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.
Merzak A; McCrea S; Koocheckpour S; Pilkington GJ
Br J Cancer; 1994 Aug; 70(2):199-203. PubMed ID: 8054266
[TBL] [Abstract][Full Text] [Related]
15. Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes.
Bonnet F; Cao Z; Cooper ME; Cox AJ; Kelly DJ; Gilbert RE
Diabetes Metab; 2003 Sep; 29(4 Pt 1):386-92. PubMed ID: 14526266
[TBL] [Abstract][Full Text] [Related]
16. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
17. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T
Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Tranilast on Transforming Growth Factor-Beta-Induced Protein in Granular Corneal Dystrophy Type 2 Corneal Fibroblasts.
Kim TI; Lee H; Hong HK; Kim KS; Choi SI; Maeng YS; Kim EK
Cornea; 2015 Aug; 34(8):950-8. PubMed ID: 26020822
[TBL] [Abstract][Full Text] [Related]
19. Tranilast Inhibits TGF-β1-induced Epithelial-mesenchymal Transition and Invasion/Metastasis
Takahashi K; Menju T; Nishikawa S; Miyata R; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Hamaji M; Ohsumi A; Chen-Yoshikawa TF; Sato T; Sonobe M; Date H
Anticancer Res; 2020 Jun; 40(6):3287-3296. PubMed ID: 32487624
[TBL] [Abstract][Full Text] [Related]
20. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
